Cargando…
Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
Autores principales: | Jarius, Sven, Haas, Jürgen, Wildemann, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971044/ https://www.ncbi.nlm.nih.gov/pubmed/36333454 http://dx.doi.org/10.1007/s00415-022-11417-z |
Ejemplares similares
-
Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis
por: Jarius, Sven, et al.
Publicado: (2022) -
Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia
por: Jarius, Sven, et al.
Publicado: (2013) -
‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC
por: Jarius, S., et al.
Publicado: (2015) -
Arhgap17, a RhoGTPase activating protein, regulates mucosal and epithelial barrier function in the mouse colon
por: Lee, So-young, et al.
Publicado: (2016) -
The role of GTPase-activating protein ARHGAP26 in human cancers
por: Zhang, Lingye, et al.
Publicado: (2021)